Coriell Institute for Medical Research
Coriell Institute of Medical Research
  • Request a Quote
  • Donate
  • Login
  • View Cart
Sample Catalog | Custom Services | Core Facilities | Genomic Data Search
  • Biobank
    • NIGMS
    • NINDS
    • NIA
    • NHGRI
    • NEI
    • Allen Cell Collection
    • Rett Syndrome iPSC Collection
    • Autism Research Resource
    • HD Community Biorepository
    • CDC Cell and DNA
    • J. Craig Venter Institute
    • Orphan Disease Center Collection
    • All Biobanks
  • Research
    • Overview
    • Meet Our Scientists
      • Our Faculty
      • Our Scientific Staff
    • Camden Cancer Research Center
    • Epigenetic Therapies SPORE
    • Core Facilities
    • Epigenomics
    • Camden Opioid Research Initiative (CORI)
    • The Issa & Jelinek Lab
    • The Jian Huang Lab
    • The Luke Chen Lab
      • The Lab
      • The Team
      • Publications
    • The Scheinfeldt Lab
    • The Shumei Song Lab
    • The Nora Engel Lab
      • The Lab
      • The Team
      • Publications
    • Publications
  • Services
    • Overview
    • Biobanking Services
      • Core Services
      • Project Management
      • Research Support Services
      • Sample Cataloging
      • Sample Collection Kits
      • Sample Data Management
      • Sample Distribution
      • Sample Management
      • Sample Procurement
      • Sample Storage
    • Bioinformatics and Biostatistics Services
    • Cellular and Molecular Services
      • Biomarker Research Solutions
      • Cell Culture
      • Nucleic Acid Isolation and Quality Control
    • Clinical Trial Support
      • Overview
      • Sample Collection
      • Data Management
      • Sample Processing and QC
      • Storage and Distribution
      • Biomarker Services
      • Data Analaysis
    • Core Facilties
      • Overview
      • Animal and Xenograft
      • Bioinformatics and Biostatistics
      • Cell Imaging
      • CRISPR Gene Engineering
      • Flow Cytometry and Cell Sorting
      • Genomics and Epigenomics
      • iPSC - Induced Pluripotent Stem Cells
      • Organoids
    • Coriell Marketplace
    • Genomic, Epigenomic and Multiomics Services
    • Stem Cells and iPSC Services
      • Core Services
      • Reprogramming
      • Characterization and Quality Control
      • Differentiated Cell Lines
      • iPSC-Derived Organoids
      • iPSC Expansion
      • iPSC Gene Editing
  • Ordering
    • Stem Cells
    • Cell Lines
    • DNA and RNA
    • Featured Products
      • FFPE
      • HMW DNA
    • Genomic Data Search
    • Search by Catalog ID
    • Help
      • Create Account
      • Order Online
      • Ordering FAQ
      • FAQs/Culture Instructions
      • Reference Materials
        • Biobanks
        • NIGMS Repository
        • NHGRI Repository
        • NINDS Repository
        • NIA Repository
        • NIST
        • GeT-RM
      • Secondary Distribution Policies
      • MTA Assurance Form
      • Shipment Policy
      • Contact Customer Service
  • About Us
    • Our History
    • Meet Our Team
    • Meet Our Board
    • Education
      • Science Fair
      • Summer Experience
      • Outreach
      • Research Program Internship
    • Press Room
      • Press Releases
      • Coriell Blog
      • Annual Report
    • Careers
      • Working at Coriell
    • Giving
      • Donate
      • Giving FAQ
    • Contact Us
    • Legal Notice
  • Login View Cart
search submit
GM26584 Fibroblast from Skin, Arm

Description:

CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG
N-GLYCANASE 1; NGLY1

Affected:

Yes

Sex:

Female

Age:

18 YR (At Sampling)

  • Overview
  • Characterizations
  • Phenotypic Data
  • External Links
  • Culture Protocols

Overview

back to top
Repository NIGMS Human Genetic Cell Repository
Subcollection Heritable Diseases
PIGI Consented Sample
Biopsy Source Arm
Cell Type Fibroblast
Tissue Type Skin
Transformant Untransformed
Sample Source Fibroblast from Skin, Arm
Race White
Country of Origin USA
Family Member 1
Family History Y
Relation to Proband proband
Confirmation Molecular characterization before cell line submission to CCR
Species Homo sapiens
Common Name Human
Remarks Clinically affected; diagnosed at 16 years old; symptoms onset at birth; mother's heart rate decreased one week before birth resulting in emergency C-section at 37 weeks gestation; decreased movement noticed by mother 2 days before birth; nuchal cord; blue in color; severe hypoxia and resuscitation; admitted to the NICU for 24 hours due to low birth weight (4 pounds 7 ounces) and small birth length; experienced projectile vomiting and was diagnosed with anal stenosis within first month of life; very high, narrow palate; crowded teeth; dry lips; kyphosis; lagopthalmos; anteverted nares; abnormal face shape; at 6 weeks parents noticed she was not smiling and seemed hypotonic; at 6 months she was not rolling or sitting, diagnosed with developmental delay; began having involuntary movements around 6-12 months which gradually worsened; seizures started at age 10 or 11 and have worsened over time; atonic seizures; failure to thrive; GERD; severe constipation; incontinence; severe scoliosis; diffuse osteopenia; fatigues easily; amennorhea; microcephaly; deep reflexes hypoactive; non-verbal; severe intellectual disability; sensorimotor neuropathy; decreased sweating due to autonomic dysfunction; central sleep apnea; corneal clouding; hypolacrima with severe corneal scarring; corneal neovascularization; alacrima; optic nerve pallor; pigmentary retinal degeneration; blurred vision; dry eyes, no tears; very dry skin; deafness; severe otitis media; movement disorder; hyperkinesis; motor tone decreased in trunk and increased extensor tone in extremities; non-ambulatory; choreiform movements; dysmetria; tachycardia, heart rate 118 at rest; respiratory rate is 20 breaths per minute; elevated hepatic transaminases; slightly low prealbumin level at 17 mg/dL; TSH slightly elevated 5.19 mclU/mL; underweight; BMI 14.3; head circumference 52 cm; delayed fine and gross motor skills; exaggerated cellular immune processes; cranial nerve exam found poor oral muscle tone, hyperactive gag, upper and low face is weak; QSWEAT found abnormal sweat response in a length-dependent manner suggesting that it is related to a peripheral neuropathy rather than a generalized process; EMG/nerve conduction study found electrophysiological evidence of a combined axonal and demyelinating sensorimotor polyneuropathy, EMG showed abnormalities in all muslces tested: right arm, biceps, leg, vastus medialis, medical head of gastrocnemius; MRI/MRS found deficit of NAA in all four locations studied, deficit most pronounced in left centrum semiovale, this location also demonstrates an excess of choline, paranasal sinus inflammation includes mucosal thickening and mucus retention cysts; genetic testing revealed homozygous mutation (c.1201A>T) in NGLY1 gene resulting in p.R401X; neuro imaging showed abnormality of the cerebral cortex, cerebral cortical atrophy, abnormal metabolic brain imaging, reduced brain N-acetyl aspartate levels, and elevated brain choline levels; back brace for scoliosis; Botox tx and casting of legs as child for tight heel cords; medications include Keppra 500 mg IV twice a day, Miralax 17 gm PO daily in AM; artificial tears eye drops PRN 3-4 times a day; physical and occupational therapy from age 6 months to 6 years; G-tube considered due to rapid weight loss and difficulty swallowing; wheelchair; hearing aids did not help, deafness suspected to be neurological; affected sibling (GM26585 B-lymphocyte, GM26586 fibroblast), unaffected mother (GM26587 B-lymphocyte), and unaffected father (GM26588 B-lymphocyte) also in repository.

Characterizations

back to top
PDL at Freeze 5.8
Passage Frozen 4
 
IDENTIFICATION OF SPECIES OF ORIGIN Species of Origin Confirmed by LINE assay
 
Gene NGLY1
Chromosomal Location 3p24.2
Allelic Variant 1 610661.0002; CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG
Identified Mutation ARG401TER; For discussion of the arg401-to-ter (R401X) mutation in the NGLY1 gene that was found in compound heterozygous state in a patient with congenital disorder of deglycosylation (CDDG; 615273) by Need et al. (2012), see 610661.0001.
 
Gene NGLY1
Chromosomal Location 3p24.2
Allelic Variant 2 610661.0002; CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG
Identified Mutation ARG401TER; For discussion of the arg401-to-ter (R401X) mutation in the NGLY1 gene that was found in compound heterozygous state in a patient with congenital disorder of deglycosylation (CDDG; 615273) by Need et al. (2012), see 610661.0001.

Phenotypic Data

back to top
Remarks Clinically affected; diagnosed at 16 years old; symptoms onset at birth; mother's heart rate decreased one week before birth resulting in emergency C-section at 37 weeks gestation; decreased movement noticed by mother 2 days before birth; nuchal cord; blue in color; severe hypoxia and resuscitation; admitted to the NICU for 24 hours due to low birth weight (4 pounds 7 ounces) and small birth length; experienced projectile vomiting and was diagnosed with anal stenosis within first month of life; very high, narrow palate; crowded teeth; dry lips; kyphosis; lagopthalmos; anteverted nares; abnormal face shape; at 6 weeks parents noticed she was not smiling and seemed hypotonic; at 6 months she was not rolling or sitting, diagnosed with developmental delay; began having involuntary movements around 6-12 months which gradually worsened; seizures started at age 10 or 11 and have worsened over time; atonic seizures; failure to thrive; GERD; severe constipation; incontinence; severe scoliosis; diffuse osteopenia; fatigues easily; amennorhea; microcephaly; deep reflexes hypoactive; non-verbal; severe intellectual disability; sensorimotor neuropathy; decreased sweating due to autonomic dysfunction; central sleep apnea; corneal clouding; hypolacrima with severe corneal scarring; corneal neovascularization; alacrima; optic nerve pallor; pigmentary retinal degeneration; blurred vision; dry eyes, no tears; very dry skin; deafness; severe otitis media; movement disorder; hyperkinesis; motor tone decreased in trunk and increased extensor tone in extremities; non-ambulatory; choreiform movements; dysmetria; tachycardia, heart rate 118 at rest; respiratory rate is 20 breaths per minute; elevated hepatic transaminases; slightly low prealbumin level at 17 mg/dL; TSH slightly elevated 5.19 mclU/mL; underweight; BMI 14.3; head circumference 52 cm; delayed fine and gross motor skills; exaggerated cellular immune processes; cranial nerve exam found poor oral muscle tone, hyperactive gag, upper and low face is weak; QSWEAT found abnormal sweat response in a length-dependent manner suggesting that it is related to a peripheral neuropathy rather than a generalized process; EMG/nerve conduction study found electrophysiological evidence of a combined axonal and demyelinating sensorimotor polyneuropathy, EMG showed abnormalities in all muslces tested: right arm, biceps, leg, vastus medialis, medical head of gastrocnemius; MRI/MRS found deficit of NAA in all four locations studied, deficit most pronounced in left centrum semiovale, this location also demonstrates an excess of choline, paranasal sinus inflammation includes mucosal thickening and mucus retention cysts; genetic testing revealed homozygous mutation (c.1201A>T) in NGLY1 gene resulting in p.R401X; neuro imaging showed abnormality of the cerebral cortex, cerebral cortical atrophy, abnormal metabolic brain imaging, reduced brain N-acetyl aspartate levels, and elevated brain choline levels; back brace for scoliosis; Botox tx and casting of legs as child for tight heel cords; medications include Keppra 500 mg IV twice a day, Miralax 17 gm PO daily in AM; artificial tears eye drops PRN 3-4 times a day; physical and occupational therapy from age 6 months to 6 years; G-tube considered due to rapid weight loss and difficulty swallowing; wheelchair; hearing aids did not help, deafness suspected to be neurological; affected sibling (GM26585 B-lymphocyte, GM26586 fibroblast), unaffected mother (GM26587 B-lymphocyte), and unaffected father (GM26588 B-lymphocyte) also in repository.

External Links

back to top
Gene Cards NGLY1
NCBI GTR 610661 N-GLYCANASE 1; NGLY1
615273 CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG
OMIM 610661 N-GLYCANASE 1; NGLY1
615273 CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG

Culture Protocols

back to top
Passage Frozen 4
Split Ratio 1:5
Temperature 37 C
Percent CO2 5%
Percent O2 3%
Medium Eagle's Minimum Essential Medium with Earle's salts and non-essential amino acids with 2mM L-glutamine or equivalent
Serum 15% fetal bovine serum Not inactivated
Supplement -
Pricing
International/Commercial/For-profit:
$373.00USD
U.S. Academic/Non-profit/Government:
$216.00USD
Add to Cart
How to Order
  • Ordering Instructions
  • MTA / Assurance Form
  • Statement of Research Intent Form
Related Products
Same Family
  • 3374
Miscellaneous
  • DNA on Demand
  • Custom Services

Our mission is to prevent and cure disease through biomedical research.

CONTACT US

CUSTOMER SERVICE
customerservice@coriell.org (800) 752-3805 • (856) 757-4848
Subscribe to our newsletter here

Coriell Institute for Medical Research
403 Haddon Avenue Camden, NJ 08103, USA (856) 966-7377

Ⓒ 2025 Coriell Institute. All rights reserved.

  • Facebook
  • Linkedin
  • Youtube